Genenta Science S.p.A.
GNTA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $42 | $6 | $5 |
| Gross Profit | $0 | -$42 | -$6 | -$5 |
| % Margin | – | – | – | – |
| R&D Expenses | $4,813 | $6,474 | $5,339 | $3,391 |
| G&A Expenses | $4,951 | $5,259 | $5,705 | $2,297 |
| SG&A Expenses | $4,951 | $5,259 | $5,705 | $2,297 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $9,764 | $11,733 | $11,044 | $5,687 |
| Operating Income | -$9,764 | -$11,733 | -$11,044 | -$5,687 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $852 | $87 | $2,566 | $158 |
| Pre-Tax Income | -$8,912 | -$11,645 | -$8,478 | -$5,529 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$8,912 | -$11,645 | -$8,478 | -$5,529 |
| % Margin | – | – | – | – |
| EPS | -0.49 | -0.64 | -0.47 | -0.31 |
| % Growth | 23.4% | -36.2% | -51.6% | – |
| EPS Diluted | -0.49 | -0.64 | -0.47 | -0.31 |
| Weighted Avg Shares Out | 18,273 | 18,216 | 18,217 | 18,217 |
| Weighted Avg Shares Out Dil | 18,273 | 18,217 | 18,217 | 18,217 |
| Supplemental Information | – | – | – | – |
| Interest Income | $81 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $12 |
| Depreciation & Amortization | $45 | $42 | $6 | $5 |
| EBITDA | -$9,720 | -$11,690 | -$11,038 | -$5,682 |
| % Margin | – | – | – | – |